Plasma microRNA signature of patients with IgA nephropathy

Area of Science:

• Nephrology
• Molecular Biology
• Biomarker Discovery

Background:

• Immunoglobulin A nephropathy (IgAN) is a common primary glomerulonephritis.
• Identifying reliable biomarkers for IgAN diagnosis and staging is crucial.
• MicroRNAs (miRNAs) are small non-coding RNAs with regulatory roles in various diseases.

Purpose of the Study:

• To identify differentially expressed miRNAs in the plasma of IgAN patients.
• To evaluate the diagnostic potential of identified miRNAs as biomarkers for IgAN.
• To investigate the correlation between miRNA expression and disease severity in IgAN.

Main Methods:

• Quantitative reverse transcription polymerase chain reaction (qRT-PCR) using a comprehensive miRNA panel.
• Screening of 48 miRNAs in pooled samples, followed by validation in training and testing cohorts.
• Plasma samples from 32 IgAN patients and 31 normal controls (NCs) for training, and 51 IgAN patients and 51 NCs for testing.
• Assessment of renal pathology using Lee's grading system.

Main Results:

• A plasma miRNA signature comprising four upregulated miRNAs (miR-148a-3p, miR-150-5p, miR-20a-5p, and miR-425-3p) was identified.
• The miRNA signature achieved an area under the receiver operating characteristic curve (AUC) of 0.80 in the training set and 0.76 in the testing set.
• Higher expression of these four miRNAs was observed in early-stage IgAN (Lee's grade I-II) compared to advanced stages (grade III-V).

Conclusions:

• Plasma levels of miR-148a-3p, miR-150-5p, miR-20a-5p, and miR-425-3p are significantly upregulated in IgAN patients.
• This miRNA signature shows potential as a non-invasive biomarker for IgAN, especially in early disease stages.
• Further research is warranted to elucidate the specific roles of these miRNAs in IgAN pathogenesis and progression.